Wellness Update: Europe: E.U. Approves Blood Thinner From Bristol-Myers, Pfizer - WSJ.com

E.U. Approves Blood Thinner From Bristol-Myers, Pfizer - WSJ.com: "European health regulators approved a new blood thinner from Pfizer Inc. and Bristol-Myers Squibb Co. for the prevention of blood clots in people who have undergone hip or knee replacement surgery.

The drug, Eliquis, was approved by the European Commission for sale in the 27 countries of the European Union. It was the first regulatory approval for Eliquis, which analysts think could eventually generate annual sales exceeding $1 billion."